Hans‐Peter Hartung

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

Richard AC Hughes, Peter D. Donofrio, Vera Bril et al. · The Lancet Neurology · 2008 · 669 citations · Full text

Life Sciences, Immunology, Neurology +14

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 269 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +11

P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy

Wei Xing Yan, Juan J. Archelos, Hans‐Peter Hartung et al. · Annals of Neurology · 2001 · 162 citations · Full text

Life Sciences, Immunology, Neurology +17

International Guillain‐Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain‐Barré syndrome

Bart C. Jacobs, Bianca van den Berg, Christine Verboon et al. · Journal of the Peripheral Nervous System · 2017 · 115 citations · Full text

Medicine, Neurology, Neuroscience +12

Differential expression of matrix metalloproteinases in bacterial meningitis

Bernd C. Kieseier, Robert Paul, Uwe Koedel et al. · Brain · 1999 · 103 citations · Full text

Life Sciences, Pathobiology, Pathology +15